Apheris Gains Momentum with Pharma Pivot in 2023

Apheris's 2023 pivot to pharma and life sciences sparks a fourfold revenue surge. Discover how this strategic shift is transforming the company.

A vibrant, modern illustration of the pharmaceutical and life sciences industry, featuring molecules
Apheris Gains Momentum with Pharma Pivot in 2023

Apheris pivoted in 2023 to focus on pharma and life sciences, which resulted in a fourfold revenue increase.

Source